keyword
Keywords American society of peritoneal...

American society of peritoneal surface malignancies

https://read.qxmd.com/read/36468401/influence-of-insurance-status-on-the-postoperative-outcomes-of-cytoreductive-surgery-and-hipec
#1
JOURNAL ARTICLE
Boateng Kubi, Richard Nudotor, Nadege Fackche, Julian Rowe, Jordan M Cloyd, Ahmed Ahmed, Travis E Grotz, Keith Fournier, Sean Dineen, Jula Veerapong, Joel M Baumgartner, Callisia Clarke, Sameer H Patel, Vikrom Dhar, Laura Lambert, Daniel E Abbott, Courtney Pokrzywa, Mustafa Raoof, Byrne Lee, Mohammad Y Zaidi, Shishir K Maithel, Fabian M Johnston, Jonathan B Greer
BACKGROUND: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is increasingly performed for peritoneal surface malignancies but remains associated with significant morbidity. Scant research is available regarding the impact of insurance status on postoperative outcomes. METHODS: Patients undergoing CRS/HIPEC between 2000 and 2017 at 12 participating sites in the US HIPEC Collaborative were identified. Univariate and multivariate analyses were used to compare the baseline characteristics, operative variables, and postoperative outcomes of patients with government, private, or no insurance...
December 5, 2022: Journal of Surgical Oncology
https://read.qxmd.com/read/36457647/perioperative-chemotherapy-in-colorectal-cancer-with-peritoneal-metastases-a-global-propensity-score-matched-study
#2
JOURNAL ARTICLE
Peter H Cashin, Jesus Esquivel, Stein G Larsen, Winston Liauw, Nayef A Alzahrani, David L Morris, Vahan Kepenekian, Isabelle Sourrouille, Frédéric Dumont, Jean-Jacques Tuech, Cécilia Ceribelli, Beranger Doussot, Olivia Sgarbura, Francois Quenet, Olivier Glehen, Oliver M Fisher
BACKGROUND: There is a paucity of studies evaluating perioperative systemic chemotherapy in conjunction with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colorectal cancer peritoneal metastases (CRCPM). The aim was to evaluate neoadjuvant and/or adjuvant systemic therapy in CRCPM. METHODS: Patients with CRCPM from 39 treatment centres globally from January 1, 1991, to December 31, 2018, who underwent CRS+HIPEC were identified and stratified according to neoadjuvant/adjuvant use...
January 2023: EClinicalMedicine
https://read.qxmd.com/read/34222676/current-management-of-malignant-bowel-obstructions-a-survey-of-acute-care-surgeons-and-surgical-oncologists
#3
JOURNAL ARTICLE
Josh Bleicher, Laura A Lambert, Courtney L Scaife, Alexander Colonna
BACKGROUND: Malignant small bowel obstructions (MSBOs) are one of the most challenging problems surgeons encounter, and evidence-based treatment recommendations are lacking. We hypothesized that current opinions on MSBO management differ between acute care surgeons (ACSs) and surgical oncologists (SOs). METHODS: We developed three case scenarios describing patients with previously treated cancer who developed an MSBO. Each case had five to six alternate scenarios, intended to capture the heterogeneity of MSBO presentations...
2021: Trauma Surgery & Acute Care Open
https://read.qxmd.com/read/31004870/perioperative-morbidity-of-gastrectomy-during-crs-hipec-an-acs-nsqip-analysis
#4
JOURNAL ARTICLE
Anghela Z Paredes, Francisco A Guzman-Pruneda, Sherif Abdel-Misih, John Hays, Mary E Dillhoff, Timothy M Pawlik, Jordan M Cloyd
BACKGROUND: Formal gastrectomy is occasionally required to achieve complete cytoreduction for patients with peritoneal surface malignancies. In addition, the role of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with gastric cancer is increasingly being explored. Nevertheless, data on the safety of gastrectomy at the time of CRS-HIPEC are limited. METHODS: The American College of Surgeons-National Surgical Quality Improvement Program databases from 2005 to 2016 were used to identify patients who underwent CRS-HIPEC...
September 2019: Journal of Surgical Research
https://read.qxmd.com/read/30328620/local-cancer-recurrence-the-realities-challenges-and-opportunities-for-new-therapies
#5
REVIEW
David A Mahvi, Rong Liu, Mark W Grinstaff, Yolonda L Colson, Chandrajit P Raut
Locoregional recurrence negatively impacts both long-term survival and quality of life for several malignancies. For appropriate-risk patients with an isolated, resectable, local recurrence, surgery represents the only potentially curative therapy. However, oncologic outcomes remain inferior for patients with locally recurrent disease even after macroscopically complete resection. Unfortunately, these operations are often extensive, with significant perioperative morbidity and mortality. This review highlights selected malignancies (mesothelioma, sarcoma, lung cancer, breast cancer, rectal cancer, and peritoneal surface malignancies) in which surgical resection is a key treatment modality and local recurrence plays a significant role in overall oncologic outcome with regard to survival and quality of life...
November 2018: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/30295939/erratum-re-the-american-society-of-peritoneal-surface-malignancies-multi-institution-evaluation-of-1-051-advanced-ovarian-cancer-patients-undergoing-cytoreductive-surgery-and-hipec-an-introduction-of-the-peritoneal-surface-disease-severity-score-journal-of
#6
JOURNAL ARTICLE
Jason M Foster, Richard Sleightholm, Lynette Smith, Wim Ceelen, Marcello Deraco, Yusuf Yildirim, Edward Levine, Cristobal Muñoz-Casares, Olivier Glehen, Asish Patel, Jesus Esquivel
No abstract text is available yet for this article.
September 2018: Journal of Surgical Oncology
https://read.qxmd.com/read/30003349/a-minimally-invasive-approach-for-peritonectomy-procedures-and-hyperthermic-intraperitoneal-chemotherapy-hipec-in-limited-peritoneal-carcinomatosis-the-american-society-of-peritoneal-surface-malignancies-aspsm-multi-institution-analysis
#7
JOURNAL ARTICLE
A Arjona-Sanchez, J Esquivel, O Glehen, G Passot, K K Turaga, D Labow, S Rufian-Peña, R Morales, K van der Speeten
BACKGROUND: Minimally invasive surgery is playing an increasing role in the treatment of patients with gastrointestinal and gynaecological malignancies as the data show reduced morbidity, faster recovery and similar oncological outcome when compared to open procedures. MATERIALS AND METHODS: The American Society of Peritoneal Surface Malignancies (ASPSM) conducted a retrospective study to analyse peritonectomy procedures and HIPEC done via the laparoscopic route...
March 2019: Surgical Endoscopy
https://read.qxmd.com/read/27900630/current-delivery-of-hyperthermic-intraperitoneal-chemotherapy-with-cytoreductive-surgery-cs-hipec-and-perioperative-practices-an-international-survey-of-high-volume-surgeons
#8
JOURNAL ARTICLE
Allison H Maciver, Eisar Al-Sukhni, Jesus Esquivel, Joseph J Skitzki, John M Kane, Valerie A Francescutti
BACKGROUND: Cytoreductive surgery and heated intraperitoneal chemotherapy (CS/HIPEC) is performed for selected indications at a limited number of specialized centers worldwide. Currently there is no standardized approach to the perioperative care process. We sought to capture current practices in the perioperative management of patients who undergo CS/HIPEC at high-volume centers. METHODS: Surgeon members of the American Society of Peritoneal Surface Malignancies working at high-volume CS/HIPEC centers (>10 cases/year) were invited to complete an online survey...
April 2017: Annals of Surgical Oncology
https://read.qxmd.com/read/27792292/the-american-society-of-peritoneal-surface-malignancies-multi-institution-evaluation-of-1-051-advanced-ovarian-cancer-patients-undergoing-cytoreductive-surgery-and-hipec-an-introduction-of-the-peritoneal-surface-disease-severity-score
#9
MULTICENTER STUDY
Jason M Foster, Richard Sleightholm, Lynette Smith, Wim Ceelen, Marcello Deraco, Yusuf Yildirim, Edward Levine, Cristobal Muñoz-Casares, Olivier Glehen, Asish Patel, Jesus Esquivel
BACKGROUND: Standard treatment for ovarian epithelial cancer (OEC) consists of cytoreductive surgery (CRS) and a platinum-taxane chemotherapy combination. There is increasing interest in evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with stage IIIC/IV disease. The peritoneal surface disease severity score (PSDSS) was introduced as a basis to improve patient selection for this therapy in OEC. METHODS: The charts of 1,051 patients with advanced OEC who underwent CRS/HIPEC were retrospectively evaluated using the following preoperatively obtained criteria: symptoms, peritoneal dissemination, and tumor histology...
December 2016: Journal of Surgical Oncology
https://read.qxmd.com/read/25088304/the-american-society-of-peritoneal-surface-malignancies-evaluation-of-hipec-with-mitomycin-c-versus-oxaliplatin-in-539-patients-with-colon-cancer-undergoing-a-complete-cytoreductive-surgery
#10
MULTICENTER STUDY
Arancha Prada-Villaverde, Jesus Esquivel, Andrew M Lowy, Maurie Markman, Terence Chua, Joerg Pelz, Dario Baratti, Joel M Baumgartner, Richard Berri, Pedro Bretcha-Boix, Marcello Deraco, Guillermo Flores-Ayala, Olivier Glehen, Alberto Gomez-Portilla, Santiago González-Moreno, Martin Goodman, Evgenia Halkia, Shigeki Kusamura, Mecker Moller, Guillaume Passot, Marc Pocard, George Salti, Armando Sardi, Maheswari Senthil, John Spiliotis, Juan Torres-Melero, Kiran Turaga, Richard Trout
BACKGROUND: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) are gaining acceptance as treatment for selected patients with colorectal cancer with peritoneal carcinomatosis (CRCPC). Tremendous variations exist in the HIPEC delivery. METHODS: The American Society of Peritoneal Surface Malignancies (ASPSM) examined the overall survival in patients with CRCPC who underwent a complete cytoreduction and HIPEC with Oxaliplatin vs. Mitomycin C (MMC), stratifying them by the Peritoneal Surface Disease Severity Score (PSDSS)...
December 2014: Journal of Surgical Oncology
https://read.qxmd.com/read/25043759/american-society-of-peritoneal-surface-malignancies-opinion-statement-on-defining-expectations-from-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-in-patients-with-colorectal-cancer
#11
JOURNAL ARTICLE
Jesus Esquivel, Pompiliu Piso, Vic Verwaal, Thomas Bachleitner-Hofmann, Olivier Glehen, Santiago González-Moreno, Marcello Deraco, Joerg Pelz, Richard Alexander, Gabriel Glockzin
No abstract text is available yet for this article.
December 2014: Journal of Surgical Oncology
https://read.qxmd.com/read/24854493/the-american-society-of-peritoneal-surface-malignancies-aspsm-multiinstitution-evaluation-of-the-peritoneal-surface-disease-severity-score-psdss-in-1-013-patients-with-colorectal-cancer-with-peritoneal-carcinomatosis
#12
MULTICENTER STUDY
Jesus Esquivel, Andrew M Lowy, Maurie Markman, Terence Chua, Joerg Pelz, Dario Baratti, Joel M Baumgartner, Richard Berri, Pedro Bretcha-Boix, Marcello Deraco, Guillermo Flores-Ayala, Olivier Glehen, Alberto Gomez-Portilla, Santiago González-Moreno, Martin Goodman, Evgenia Halkia, Shigeki Kusamura, Mecker Moller, Guillaume Passot, Marc Pocard, George Salti, Armando Sardi, Maheswari Senthil, John Spilioitis, Juan Torres-Melero, Kiran Turaga, Richard Trout
BACKGROUND: Extensive clinical experience suggests that hyperthermic intraperitoneal chemotherapy (HIPEC) may play an important role in the management of colorectal cancer patients with peritoneal carcinomatosis (CRCPC). However, there remains no established nonsurgical process to rationally select patients for this management, either for inclusion/stratification in clinical trials or as a component of standard of care. The Peritoneal Surface Disease Severity Score (PSDSS) was introduced as a basis to improve patient selection...
December 2014: Annals of Surgical Oncology
https://read.qxmd.com/read/23990289/morbidity-and-mortality-of-cytoreduction-with-intraperitoneal-chemotherapy-outcomes-from-the-acs-nsqip-database
#13
JOURNAL ARTICLE
Edmund K Bartlett, Chelsey Meise, Robert E Roses, Douglas L Fraker, Rachel R Kelz, Giorgos C Karakousis
BACKGROUND: Cytoreduction with intraperitoneal chemotherapy (IPC) for treatment of peritoneal surface malignancies is increasingly utilized. However, the described morbidity and mortality rates are based predominantly on the experience at high-volume centers. We analyzed the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database for a nationwide perspective on morbidity and mortality associated with IPC. METHODS: The NSQIP database was queried for all patients undergoing IPC and cytoreduction from 2005 to 2011...
May 2014: Annals of Surgical Oncology
https://read.qxmd.com/read/23793364/consensus-guidelines-from-the-american-society-of-peritoneal-surface-malignancies-on-standardizing-the-delivery-of-hyperthermic-intraperitoneal-chemotherapy-hipec-in-colorectal-cancer-patients-in-the-united-states
#14
REVIEW
K Turaga, E Levine, R Barone, R Sticca, N Petrelli, L Lambert, G Nash, M Morse, R Adbel-Misih, H R Alexander, F Attiyeh, D Bartlett, A Bastidas, T Blazer, Q Chu, K Chung, L Dominguez-Parra, N J Espat, J Foster, K Fournier, R Garcia, M Goodman, N Hanna, L Harrison, R Hoefer, M Holtzman, J Kane, D Labow, B Li, A Lowy, P Mansfield, E Ong, C Pameijer, J Pingpank, M Quinones, R Royal, G Salti, A Sardi, P Shen, J Skitzki, J Spellman, J Stewart, J Esquivel
BACKGROUND: The American Society of Peritoneal Surface Malignancies (ASPSM) is a consortium of cancer centers performing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC). This is a position paper from the ASPSM on the standardization of the delivery of HIPEC. METHODS: A survey was conducted of all cancer centers performing HIPEC in the United States. We attempted to obtain consensus by the modified method of Delphi on seven key HIPEC parameters: (1) method, (2) inflow temperature, (3) perfusate volume, (4) drug, (5) dosage, (6) timing of drug delivery, and (7) total perfusion time...
May 2014: Annals of Surgical Oncology
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.